|
[1]
|
A. Inchauspe, “D-Phenylalanine Injection over K-1 Yongquan: A Theoretical Way of Upgrading Survival Rates in CPR,” BIT’s 8th Annual Congress of International Drug Discovery Science and Technology (IDDST), Beijing, 23-26 October 2010.
|
|
[2]
|
J. Wang, “Cardiovascular Safety: How to Develop Risk Assessment,” BIT’s 8th Annual Congress of International Drug Discovery Science and Technology (IDDST), Beijing, 23-26 October 2010
|
|
[3]
|
A. Inchauspe, “Fármaco-Vigilancia y Muerte Súbita,” Jornadas Multidiscipinarias del HINEA y C “Dr. Alejandro Korn”, Melchor Romero, La Plata, 2011.
|
|
[4]
|
F. Desertenne, “La Tachicardie Ventriculaire a Deux Foyers Repposes Veriables,” Archives des Maladies du Coeur et des Vaisseaux, Vol. 59, 1966, pp. 263-272.
|
|
[5]
|
M. Lanzotti and N. Citta, “Síndrome de QT Largo Adquirido: Torsade de Pointes,” Univ. Buenos Aires, Universitá degli Studi de’ll Insubria, 2003.
http://www.fac.org.ar/tcvc/llave/c312/lazotti.PDF
|
|
[6]
|
E. Whitsel and P. Rautaharju, “Electrocardiography QT Interval Prolongation and Risk of Primary Cardiac Arrest in Diabetic Patients,” American Diabetes Association, 2005.
|
|
[7]
|
A. Inchauspe, “Torsadogenic Index: A Proposal to Improve Survival Rates in Cardiac Arrests Due to Prescribed Drugs,” Frontiers in Pharmacology, Vol. 3, 2012, p. 99.
http://dx.doi.org/10.3389/fphar.2012.00099
|
|
[8]
|
A. Inchauspe, “Recent Advances in Theories and Practice in Chinese Medicine,” In: Traditional Chinese Medical Criteria about the Use of Yongquan as a Life Support Maneuver, InTech, Croatia, 2011, pp. 362-366.
http://dx.doi.org/10.5772/29138
|
|
[9]
|
A. Inchauspe, “Traditional Chinese Medicine and Brain Protection: Can Its Principles Be Consistent with Western Science?” 9th IBIA International Brain Injury Association Congress, Edimburgh, 23-26 March 2012.
|
|
[10]
|
Ling Shu, “Origin and Gathering (Gen Jie),” Chapter 5.
|
|
[11]
|
A. Inchauspe, “Risk Management Project Applied to Torsadogenic Index,” 5th International Conference on Drug Discovery and Therapy, Dubai, 18-21 February 2013.
|
|
[12]
|
A. Inchauspe, “Torsadogenic Index: A Vanguard Risk Management Risk Measure into the Risk Statement Strategy,” Drug Discovery & Therapy World Congress, Boston, 3-6 June 2013.
|
|
[13]
|
D. Iyer, “Optimum Patient Care through Appropiate Drug-Safety Monitoring,” IDDST, 2010.
|
|
[14]
|
J. Kattwinkel and S. Niermeyer, “ILCOR Advisory Statements: Resuscitation of the Newborn Infant. An Advisory Statement from the Pediatric working Group of the International Liaison Committee on Resuscitation,” Circulation, Vol. 99, 1999, pp. 1927-1938.
http://dx.doi.org/10.1161/01.CIR.99.14.1927
|
|
[15]
|
N. Swedborg, “Drug Abuse and Dependence Liability Assessment in Safety Pharmacology,” BIT’s 8th Annual Congress of International Drug Discovery Science and Technology (IDDST), Beijing, 23-26 October 2010.
|
|
[16]
|
Ling Shu, “Beginning and Ending (Zhong Zhui),” Chapter 9.
|
|
[17]
|
F. Dessertenne, A. Fabiato and P. Courmel, “Un Chapitre Nouveau Délectrocardiographie: Les Variations Progressives de Lámplitude de L’électrocardiogramme,” Actual Cardio. Angeio. Int, Vol. 15, 1966, pp. 241-258.
|
|
[18]
|
J. López-Valcárcel, “10 Preguntas Frecuentes Sobre el Síndrome del Qt Largo.”
http://www.qtsyndrome.ch/faqsp.html
|
|
[19]
|
B. J. Maron and N. A. Mark Estes III, “Conmotio Cordis,” New England Journal of Medicine, Vol. 362, No. 10, 2010, pp. 917-927.
http://dx.doi.org/10.1056/NEJMra0910111
|
|
[20]
|
A. Inchauspe, “Traditional Chinese Medicine K-1 Yongquan and Resuscitation: Another Kind of ‘Lazarus Phenomnon’,” Resuscitation, Vol. 81, No. 4, 2009, pp. 505-506.
http://dx.doi.org/10.1016/j.resuscitation.2009.12.009
|
|
[21]
|
A. Inchauspe, “Sudden, Predictable and Preventable Death in Pharmacological Cardio Safety,” 5th International Conference on Drug Discovery and Therapy, Dubai, 18-21 February 2013.
|
|
[22]
|
M. Ugarte, “Detección precoz de Enfermedades Endócrino-Metabólicas en el Recién Nacido,” Comunidad de Madrid. www.madrid.org
|